376
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Quality of Antimalarial Drugs in East Africa: A Systematic Review

, ORCID Icon, ORCID Icon & ORCID Icon
Pages 6085-6092 | Received 01 May 2022, Accepted 28 Sep 2022, Published online: 21 Oct 2022

References

  • World Health Organization. Malaria Fact sheet - World malaria report 2015; 2011 [ September 5, 2012]: 6–8. Available from: http://www.who.int/malaria/world_malaria_report_2011/WMR2011_factsheet.pdf. Accessed September 9, 2022.
  • World malaria report 2020: 20 years of global progress and challenges. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.
  • Gomes M, Wayling S, Pang L. Interventions to improve the use of antimalarials in South-East Asia: an overview. Bull World Health Organ. 1998;76(1):9–19.
  • Basco LK. Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication. Am J Trop Med Hyg. 2004;70(3):245–250. doi:10.4269/ajtmh.2004.70.245
  • Enayati A, Hemingway J. Malaria management: past, present, and future. Annu Rev Entomol. 2010;55(1):569–591. doi:10.1146/annurev-ento-112408-085423
  • World Health Organization. Guidelines for the treatment of malaria. World Health Organization; 2015.
  • Tschida SD. A Systematic Review on Antibiotic Quality [Master’s thesis], University of Oslo/Norway, The Faculty of Medicine, Institute of Health and Society, Department of Community Medicine; 2016.
  • World Health Organization. Effective drug regulation: what can countries do? Theme paper for discussion, Geneva 16–19 March 1999. World Health Organization; 1999.
  • MCA. Towards safe medicines. A guide to the control of safety, quality and efficacy of human medicines in the United Kingdom. Revised edition; 1997: 1–93.
  • Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ. The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med. 2005;2(4):e100. doi:10.1371/journal.pmed.0020100
  • World Health Organization. The quality of antimalarials: a study in selected African countries. World Health Organization; 2003.
  • Hall KA, Newton PN, Green MD, et al. Characterization of counterfeit artesunate antimalarial tablets from Southeast Asia. Am J Trop Med Hyg. 2006;75(5):804–811. doi:10.4269/ajtmh.2006.75.804
  • Walker EJ, Peterson GM, Grech J, Paragalli E, Thomas J. Are we doing enough to prevent poor-quality antimalarial medicines in the developing world? BMC Public Health. 2018;18(1):1–6. doi:10.1186/s12889-018-5521-7
  • Bate R, Coticelli P, Tren R, Attaran A. Antimalarial drug quality in the most severely malarious parts of Africa–a six country study. PLoS One. 2008;3(5):e2132. doi:10.1371/journal.pone.0002132
  • World Health Organization. Survey of the quality of selected antimalarial medicines circulating in six countries of sub-Saharan Africa. WHO; 2011.
  • Thoithi GN, Abuga KO, Nguyo JM. Drug quality control in Kenya: observation in the drug analysis and research unit during the period 2001–2005. East Cent Afr J Pharmaceut Sci. 2008;11:3.
  • Kibwage IO, Ngugi JK. Sulphadoxine/pyrimethamine tablet products on the Kenyan market: quality concerns. East Cent Afr J Pharmaceut Sci. 2000;3(1):14–19.
  • Yepes-Nuñez JJ, Urrútia G, Romero-García M, The A-FS. PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol. 2021;74(9):790–799. doi:10.1016/j.rec.2021.07.010
  • Newton PN, Lee SJ, Goodman C, et al. Guidelines for field surveys of the quality of medicines: a proposal. PLoS Med. 2009;6(3):e1000052. doi:10.1371/journal.pmed.1000052
  • Abuye H, Abraham W, Kebede S, Tatiparthi R, Suleman S. Physicochemical quality assessment of antimalarial medicines: chloroquine phosphate and quinine sulfate tablets from drug retail outlets of South-West Ethiopia. Infect Drug Resist. 2020;13:691. doi:10.2147/IDR.S234684
  • Belew S, Suleman S, Mohammed T, et al. Quality of fixed dose artemether/lumefantrine products in Jimma Zone, Ethiopia. Malar J. 2019;18(1):1. doi:10.1186/s12936-019-2872-1
  • Hebron Y, Tettey JN, Pournamdari M, Watson DG. The chemical and pharmaceutical equivalence of sulphadoxine/pyrimethamine tablets sold on the Tanzanian market. J Clin Pharm Ther. 2005;30(6):575–581. doi:10.1111/j.1365-2710.2005.00687.x
  • Amin AA, Snow RW, Kokwaro GO. The quality of sulphadoxine‐pyrimethamine and amodiaquine products in the Kenyan retail sector. J Clin Pharm Ther. 2005;30(6):559–565. doi:10.1111/j.1365-2710.2005.00685.x
  • Minzi OM, Moshi MJ, Hipolite D, et al. Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar es Salaam Tanzania. J Clin Pharm Ther. 2003;28(2):117–122. doi:10.1046/j.1365-2710.2003.00470.x
  • Ndwigah S, Stergachis A, Abuga K, Mugo H, Kibwage I. The quality of anti-malarial medicines in Embu County, Kenya. Malar J. 2018;17(1):1–5. doi:10.1186/s12936-018-2482-3
  • Hussein B. Post-market in vitro quality evaluation of artemether-lumefantrine tablets marketed in Addis Ababa and selected areas of Oromia Region in Ethiopia [Doctoral dissertation]; Addis Ababa University; 2015.
  • Newton PN, McGready R, Fernandez F, et al. Manslaughter by fake artesunate in Asia—will Africa be next? PLoS Med. 2006;3(6):e197. doi:10.1371/journal.pmed.0030197
  • World Health Organization. Tool for visual inspection. Geneva, Switzerland. 2005; Available from: https://www.globalforumljd.org/sites/default/files/documents/virtualLibrary/USP%20VisualInspectionTool%20%282005%29.pdf.
  • World Health Organization. Tool for visual inspection, A checklist for visual inspection of medicines in order to identify suspicious products for further examination, Geneva: World Health Organization. Geneva World Heal Organ [Internet]. 2015; Available from: http://www.whpa.org/Toolkit_BeAware_Inspection.pdf. Accessed September 29, 2022.
  • Umeta B, Bekele A, Mohammed T, Duguma M, Teshome H, Mekonnen Y. Dissolution profile evaluation of eight brands of metformin hydrochloride tablets available in Jimma, Southwest Ethiopia. Diabetes Metab Syndr Obes. 2021;14:3499. doi:10.2147/DMSO.S316187
  • Onwujekwe O, Kaur H, Dike N, et al. Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria. Malar J. 2009;8(1):1–9. doi:10.1186/1475-2875-8-22
  • Tabernero P, Fernández FM, Green M, Guerin PJ, Newton PN. Mind the gaps - The epidemiology of poor-quality anti-malarials in the malarious world - Analysis of the WorldWide antimalarial resistance network database. Malar J. 2014;13(1):1–14. doi:10.1186/1475-2875-13-139